Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 118-121, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mamotte, C. D.
Right arrow Articles by van Bockxmeer, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mamotte, C. D.
Right arrow Articles by van Bockxmeer, F. M.

Clinical Chemistry, Vol 39, 118-121, Copyright © 1993 by American Association for Clinical Chemistry

A robust strategy for screening and confirmation of familial defective apolipoprotein B-100

CD Mamotte and FM van Bockxmeer
Department of Biochemistry, Royal Perth Hospital, Western Australia.

The diagnosis of familial defective apolipoprotein B-100 (FDB) has been facilitated by the use of mutagenic polymerase chain reaction (PCR) primers to introduce restriction sites at the FDB gene locus. We describe a two-test strategy for diagnosing FDB that overcomes the potential for error in single-test methods based on such techniques. We introduce an Sau96I restriction site for PCR products of the normal apolipoprotein B allele. Incomplete digestion of the PCR product with Sau96I suggests an FDB heterozygote, although a false-positive result due to nonideal digestion conditions remains a possibility. In such cases we use a second test that introduces an ScaI restriction site in PCR products of the FDB allele. The diagnosis is confirmed if half of this product can be digested with ScaI. Both tests use 0.25 units of Taq polymerase and are robust with respect to annealing temperature (31- 58 degrees C) and to Mg2+ concentration (1.0-3.2 mmol/L).


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
K. E Liyanage, A. J Hooper, J. C Defesche, J. R Burnett, and F. M van Bockxmeer
High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations
Ann Clin Biochem, March 1, 2008; 45(2): 170 - 176.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Fisher, H. Scharnagl, M. M. Hoffmann, K. Kusterer, D. Wittmann, H. Wieland, W. Gross, and W. Marz
Mutations in the Apolipoprotein (apo) B-100 Receptor-binding region: Detection of apo B-100 (Arg3500->Trp) Associated with Two New Haplotypes and Evidence That apo B-100 (Glu3405->Gln) Diminishes Receptor-mediated Uptake of LDL
Clin. Chem., July 1, 1999; 45(7): 1026 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Haddad, I. N. M. Day, S. Hunt, R. R. Williams, S. E. Humphries, and P. N. Hopkins
Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred
J. Lipid Res., June 1, 1999; 40(6): 1113 - 1122.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Y.-T. Mak, C.-P. Pang, B. Tomlinson, J. Zhang, Y.-S. Chan, T. W. L. Mak, and J. R. L. Masarei
Mutations in the Low-Density Lipoprotein Receptor Gene in Chinese Familial Hypercholesterolemia Patients
Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1600 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. R. Miserez and U. Keller
Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1719 - 1729.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.